235 related articles for article (PubMed ID: 33660278)
21. Usefulness of Elevated Troponin to Predict Death in Patients With COVID-19 and Myocardial Injury.
Majure DT; Gruberg L; Saba SG; Kvasnovsky C; Hirsch JS; Jauhar R;
Am J Cardiol; 2021 Jan; 138():100-106. PubMed ID: 33058800
[TBL] [Abstract][Full Text] [Related]
22. Relationship Between Myocardial Injury During Index Hospitalization for SARS-CoV-2 Infection and Longer-Term Outcomes.
Weber B; Siddiqi H; Zhou G; Vieira J; Kim A; Rutherford H; Mitre X; Feeley M; Oganezova K; Varshney AS; Bhatt AS; Nauffal V; Atri DS; Blankstein R; Karlson EW; Di Carli M; Baden LR; Bhatt DL; Woolley AE
J Am Heart Assoc; 2022 Jan; 11(1):e022010. PubMed ID: 34970914
[TBL] [Abstract][Full Text] [Related]
23. Reduced cardiac function is associated with cardiac injury and mortality risk in hospitalized COVID-19 Patients.
Chen LQ; Burdowski J; Marfatia R; Weber J; Gliganic K; Diaz N; Ramjattan N; Zheng H; Mihalatos D; Wang L; Barasch E; Leung A; Gopal A; Craft J; Ren X; Stergiopoulos K; Jeremias A; Petrossian G; Robinson N; Levine J; Shlofmitz RA; Gulotta RJ; Muehlbauer SM; Lucore CL; Cao JJ
Clin Cardiol; 2020 Dec; 43(12):1547-1554. PubMed ID: 33280140
[TBL] [Abstract][Full Text] [Related]
24. High sensitivity Troponin-T for prediction of adverse events in patients with COVID-19.
Singh N; Anchan RK; Besser SA; Belkin MN; Cruz MD; Lee L; Yu D; Mehta N; Nguyen AB; Alenghat FJ
Biomarkers; 2020 Dec; 25(8):626-633. PubMed ID: 32981387
[TBL] [Abstract][Full Text] [Related]
25. Myocardial injury and COVID-19: Serum hs-cTnI level in risk stratification and the prediction of 30-day fatality in COVID-19 patients with no prior cardiovascular disease.
Cao J; Zheng Y; Luo Z; Mei Z; Yao Y; Liu Z; Liang C; Yang H; Song Y; Yu K; Gao Y; Zhu C; Huang Z; Qian J; Ge J
Theranostics; 2020; 10(21):9663-9673. PubMed ID: 32863952
[No Abstract] [Full Text] [Related]
26. Prevalence and Impact of Myocardial Injury in Patients Hospitalized With COVID-19 Infection.
Lala A; Johnson KW; Januzzi JL; Russak AJ; Paranjpe I; Richter F; Zhao S; Somani S; Van Vleck T; Vaid A; Chaudhry F; De Freitas JK; Fayad ZA; Pinney SP; Levin M; Charney A; Bagiella E; Narula J; Glicksberg BS; Nadkarni G; Mancini DM; Fuster V;
J Am Coll Cardiol; 2020 Aug; 76(5):533-546. PubMed ID: 32517963
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic and prognostic utility of early measurement with high-sensitivity troponin T assay in patients presenting with chest pain.
Aldous SJ; Richards M; Cullen L; Troughton R; Than M
CMAJ; 2012 Mar; 184(5):E260-8. PubMed ID: 22291171
[TBL] [Abstract][Full Text] [Related]
28. Association between cardiac troponin I and mortality in patients with COVID-19.
Salvatici M; Barbieri B; Cioffi SMG; Morenghi E; Leone FP; Maura F; Moriello G; Sandri MT
Biomarkers; 2020 Dec; 25(8):634-640. PubMed ID: 33003961
[TBL] [Abstract][Full Text] [Related]
29. Troponin and Other Biomarker Levels and Outcomes Among Patients Hospitalized With COVID-19: Derivation and Validation of the HA
Manocha KK; Kirzner J; Ying X; Yeo I; Peltzer B; Ang B; Li HA; Lerman BB; Safford MM; Goyal P; Cheung JW
J Am Heart Assoc; 2021 Mar; 10(6):e018477. PubMed ID: 33121304
[TBL] [Abstract][Full Text] [Related]
30. Plasma 99th percentile reference limits for cardiac troponin and creatine kinase MB mass for use with European Society of Cardiology/American College of Cardiology consensus recommendations.
Apple FS; Quist HE; Doyle PJ; Otto AP; Murakami MM
Clin Chem; 2003 Aug; 49(8):1331-6. PubMed ID: 12881449
[TBL] [Abstract][Full Text] [Related]
31. Redefining Cardiac Biomarkers in Predicting Mortality of Inpatients With COVID-19.
Qin JJ; Cheng X; Zhou F; Lei F; Akolkar G; Cai J; Zhang XJ; Blet A; Xie J; Zhang P; Liu YM; Huang Z; Zhao LP; Lin L; Xia M; Chen MM; Song X; Bai L; Chen Z; Zhang X; Xiang D; Chen J; Xu Q; Ma X; Touyz RM; Gao C; Wang H; Liu L; Mao W; Luo P; Yan Y; Ye P; Chen M; Chen G; Zhu L; She ZG; Huang X; Yuan Y; Zhang BH; Wang Y; Liu PP; Li H
Hypertension; 2020 Oct; 76(4):1104-1112. PubMed ID: 32673499
[TBL] [Abstract][Full Text] [Related]
32. Myocardial injury in hospitalized patients with COVID-19 infection-Risk factors and outcomes.
Efros O; Barda N; Meisel E; Leibowitz A; Fardman A; Rahav G; Klempfner R; Grossman E
PLoS One; 2021; 16(2):e0247800. PubMed ID: 33635914
[TBL] [Abstract][Full Text] [Related]
33. Age- and sex-dependent upper reference limits for the high-sensitivity cardiac troponin T assay.
Gore MO; Seliger SL; Defilippi CR; Nambi V; Christenson RH; Hashim IA; Hoogeveen RC; Ayers CR; Sun W; McGuire DK; Ballantyne CM; de Lemos JA
J Am Coll Cardiol; 2014 Apr; 63(14):1441-8. PubMed ID: 24530665
[TBL] [Abstract][Full Text] [Related]
34. Prognostic performance of troponin in COVID-19: A diagnostic meta-analysis and meta-regression.
Wibowo A; Pranata R; Akbar MR; Purnomowati A; Martha JW
Int J Infect Dis; 2021 Apr; 105():312-318. PubMed ID: 33667694
[TBL] [Abstract][Full Text] [Related]
35. Clinical predictors of acute cardiac injury and normalization of troponin after hospital discharge from COVID-19.
Lu JQ; Lu JY; Wang W; Liu Y; Buczek A; Fleysher R; Hoogenboom WS; Zhu W; Hou W; Rodriguez CJ; Duong TQ
EBioMedicine; 2022 Feb; 76():103821. PubMed ID: 35144887
[TBL] [Abstract][Full Text] [Related]
36. Defining a reference population to determine the 99th percentile of a contemporary sensitive cardiac troponin I assay.
Keller T; Ojeda F; Zeller T; Wild PS; Tzikas S; Sinning CR; Peetz D; Münzel T; Blankenberg S; Lackner KJ
Int J Cardiol; 2013 Aug; 167(4):1423-9. PubMed ID: 22560907
[TBL] [Abstract][Full Text] [Related]
37. Myocardial Injury in Severe COVID-19 Compared With Non-COVID-19 Acute Respiratory Distress Syndrome.
Metkus TS; Sokoll LJ; Barth AS; Czarny MJ; Hays AG; Lowenstein CJ; Michos ED; Nolley EP; Post WS; Resar JR; Thiemann DR; Trost JC; Hasan RK
Circulation; 2021 Feb; 143(6):553-565. PubMed ID: 33186055
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of incidence, clinical significance, and prognostic value of circulating cardiac troponin I and T elevation in hemodynamically stable patients with suspected myocardial contusion after blunt chest trauma.
Bertinchant JP; Polge A; Mohty D; Nguyen-Ngoc-Lam R; Estorc J; Cohendy R; Joubert P; Poupard P; Fabbro-Peray P; Monpeyroux F; Poirey S; Ledermann B; Raczka F; Brunet J; Nigond J; de la Coussaye JE
J Trauma; 2000 May; 48(5):924-31. PubMed ID: 10823538
[TBL] [Abstract][Full Text] [Related]
39. Early detection of elevated cardiac biomarkers to optimise risk stratification in patients with COVID-19.
Stefanini GG; Chiarito M; Ferrante G; Cannata F; Azzolini E; Viggiani G; De Marco A; Briani M; Bocciolone M; Bragato R; Corrada E; Gasparini GL; Marconi M; Monti L; Pagnotta PA; Panico C; Pini D; Regazzoli D; My I; Kallikourdis M; Ciccarelli M; Badalamenti S; Aghemo A; Reimers B; Condorelli G;
Heart; 2020 Oct; 106(19):1512-1518. PubMed ID: 32817312
[TBL] [Abstract][Full Text] [Related]
40. [Biochemical markers of ischemic and non-ischemic myocardial damage].
Herrmann J; Volbracht L; Haude M; Eggebrecht H; Malyar N; Mann K; Erbel R
Med Klin (Munich); 2001 Mar; 96(3):144-56. PubMed ID: 11315398
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
